603980.SH
吉华集团
SSE · Basic Materials · Chemicals - Specialty · CN
CNY 6.72
+1.51%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.6B | 1.5B | 1.6B | 1.7B | 1.9B |
| Cost of Revenue | 1.4B | 1.3B | 1.4B | 1.6B | 1.9B |
| Gross Profit | 225.9M | 189.4M | 195.9M | 101.7M | 33.5M |
| Operating Expenses | |||||
| R&D Expense | 64.3M | 62.3M | 63.7M | 81.3M | 90.1M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 89.9M | 89.0M | 105.0M | 109.8M | 102.8M |
| Selling & Marketing Expense | 21.3M | 21.2M | 19.5M | 22.3M | 19.6M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 203.8M | 181.9M | 172.8M | 191.2M | 206.5M |
| Cost and Expenses | 1.6B | 1.5B | 1.6B | 1.8B | 2.1B |
| Operating Income (EBIT) | 112.9M | 66.1M | 233.3M | (238.9M) | (197.7M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 111.6M | 65.3M | 229.3M | (240.3M) | (210.6M) |
| Income Tax Expense | 21.7M | 13.9M | 59.6M | 4.8M | 3.2M |
| Bottom Line | |||||
| Net Income | 93.3M | 54.3M | 170.3M | (240.8M) | (209.6M) |
| Earnings from Cont. Ops | 89.9M | 51.4M | 169.7M | (245.1M) | (213.8M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 93.3M | 54.3M | 170.3M | (240.8M) | (209.6M) |
| Per Share | |||||
| Basic EPS | CN¥0.08 | CN¥0.01 | CN¥0.25 | (CN¥0.34) | (CN¥0.30) |
| Diluted EPS | CN¥0.08 | CN¥0.01 | CN¥0.25 | (CN¥0.34) | (CN¥0.30) |
| Revenue Per Share | CN¥2.36 | — | CN¥2.40 | CN¥2.39 | CN¥2.76 |
| Shares | |||||
| Basic Shares Outstanding | 676.2M | — | 681.3M | 708.4M | 698.8M |
| Diluted Shares Outstanding | 676.2M | — | 681.3M | 708.4M | 698.8M |
| Profitability Metrics | |||||
| EBITDA | — | 202.3M | 390.0M | (37.6M) | 16.0M |
| D&A | — | 136.2M | 156.7M | 201.3M | 213.7M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026